MentionFox
Home › funding signals › AdherePlus, Inc.
Form D · on the record

AdherePlus — $50K Form D filing, March 2026

AdherePlus, Inc. filed a Form D with the Securities and Exchange Commission on 2026-03-03.

AdherePlus, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 3, 2026. The filing reports $50K sold. Its industry group is Other Health Care. It names James Breidenstein (Executive Officer, Director), Dan Cohen (Executive Officer, Director), Peter Pitts (Director) (SEC Form D, March 3, 2026).

5 more Other Health Care raises within 90 days of this one ↓

Sell to companies like AdherePlus, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

Run the free check on AdherePlus, Inc. →

AdherePlus, Inc.

New Form D on file · 2026-03-03 · the record

$50K
raise on the record
D
filing
1
investors in
DISTRICT OF COLUMBIA
based
Open the record →

What the record says

FilingForm D
Filed2026-03-03
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
BasedWASHINGTON, DISTRICT OF COLUMBIA
CIK2113859
Accession0001493152-26-008736

Pitching, partnering or investing alongside them? See who really runs and owns AdherePlus, Inc.

Watch AdherePlus, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind AdherePlus, Inc., from the filings we hold.

More raises like this

Other Health Care raises filed within 90 days of this one, largest first.

What do you want to do with AdherePlus, Inc.?

Get the full cited report on AdherePlus, Inc.

What the filing shows about AdherePlus, Inc.

  • The filing reports $1M of the proceeds going to the company's own executives, directors or promoters.
  • 1 investor had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on AdherePlus, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

What the filing says

  • Offered: $15,000,000. Sold: $50,000. Left to sell: $14,950,000. (filing)
  • Investors: 1 had already invested. (filing)
  • Date of first sale: February 15, 2026. (filing)
  • Types of securities: Equity; Debt. (filing)
  • Item 16, payments to executive officers, directors or promoters: $1,000,000 of the proceeds is used or proposed to be used for such payments (the filing marks this amount as an estimate). The filing explains: “Executive officers of the Issuer will receive approximately 10% of any gross proceeds over $8 million but no proceeds for amounts raised below this threshold amount.” (filing)
  • On sales commissions and finders' fees: the filing adds “A maximum amount shown since the Issuer will pay a 7.5% sales commission on any equity financing and a 3.5% sales commission on any debt financing.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on AdherePlus, Inc. See pricing

Other Health Care · by week
This raise, $50K, filed week of Mar 2

Trailing twelve months. 868 filings in Other Health Care, totalled by week. The dot is this raise, $50K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on AdherePlus, Inc.?

What the filing shows about AdherePlus, Inc.

  • The filing reports $1M of the proceeds going to the company's own executives, directors or promoters.
  • 1 investor had already put money in when it filed.
  • The filing names 5 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on AdherePlus, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on AdherePlus, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind AdherePlus, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for AdherePlus, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Just raised? Share it.

AdherePlus, Inc.: Raised $50K, Form D filed 2026-03-03

Cite this page

Permanent URL: https://mentionfox.com/funding/adhereplus-inc-form-d-26000001
Last updated 2026-10-25
Primary record: SEC filing 1 · SEC filing 2
AdherePlus raised $50K — SEC Form D filing, March 2026. MentionFox, 2026-10-25. https://mentionfox.com/funding/adhereplus-inc-form-d-26000001